BlackRock
ELOX

BlackRock’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

BlackRock’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,870
Closed -$42.7K – 5558
2023
Q3 		$42.7K Sell
8,870
-20
-0.2% -$112 ﹤0.01% 5030
2023
Q2 		$34.6K Hold
8,890
– – ﹤0.01% 5132
2023
Q1 		$22.3K Hold
8,890
– – ﹤0.01% 5239
2022
Q4 		$16.2K Sell
8,890
-41
-0.5% -$198 ﹤0.01% 5399
2022
Q3 		$61K Sell
8,931
-36
-0.4% -$433 ﹤0.01% 5314
2022
Q2 		$97K Sell
8,967
-3,573
-28% -$49.3K ﹤0.01% 5252
2022
Q1 		$280K Sell
12,540
-163
-1% -$3.21K ﹤0.01% 5029
2021
Q4 		$360K Buy
12,703
+431
+4% +$18.8K ﹤0.01% 4973
2021
Q3 		$800K Buy
12,272
+7,504
+157% +$463K ﹤0.01% 4619
2021
Q2 		$380K Sell
4,768
-33,465
-88% -$2.79M ﹤0.01% 4760
2021
Q1 		$5.08M Buy
38,233
+635
+2% +$97.1K ﹤0.01% 3934
2020
Q4 		$5.99M Buy
37,598
+226
+0.6% +$27.6K ﹤0.01% 3624
2020
Q3 		$3.93M Sell
37,372
-409
-1% -$49K ﹤0.01% 3675
2020
Q2 		$4.58M Buy
37,781
+2,419
+7% +$274K ﹤0.01% 3559
2020
Q1 		$2.77M Sell
35,362
-643
-2% -$105K ﹤0.01% 3560
2019
Q4 		$10.6M Sell
36,005
-6,882
-16% -$1.39M ﹤0.01% 3221
2019
Q3 		$7.75M Buy
42,887
+2,161
+5% +$615K ﹤0.01% 3325
2019
Q2 		$16.2M Buy
40,726
+3,503
+9% +$1.47M ﹤0.01% 2963
2019
Q1 		$17.4M Sell
37,223
-114
-0.3% -$55.4K ﹤0.01% 2820
2018
Q4 		$17.9M Buy
37,337
+10,063
+37% +$5.55M ﹤0.01% 2781
2018
Q3 		$18.6M Buy
27,274
+1,037
+4% +$664K ﹤0.01% 2911
2018
Q2 		$17.9M Buy
+26,237
New +$17M ﹤0.01% 2925

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

BlackRock's ELOX Position: Q4 2023 in Review

BlackRock sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 8,870 shares — an estimated $42.7K sold.

BlackRock first reported a position in ELOX in Q2 2018 and held it in 22 quarters. The position peaked at $18.6M in Q3 2018. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • BlackRock reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • BlackRock sold 8,870 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $42.7K.
  • BlackRock first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 22 quarters.
  • BlackRock's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $18.6M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.